Where to Buy Peptide Blends in the UK
Blended vials save cost and handling steps, but they also make it impossible to attribute an observation to one compound. This guide explains when a blend is the right choice and what documentation it requires.
99% minimum by HPLCAnalysis date on every COASame working day dispatchPlain tracked parcels
A peptide blend is a single vial containing two or more compounds at defined ratios, supplied as a combined lyophilised powder. Blends reduce reconstitution steps and cost less than the equivalent separate vials. The trade-off is analytical: a blend cannot isolate a single variable, so it suits screening and combined-pathway work rather than attribution studies. A blend COA should report each component separately.
Classification
Multi-compound single-vial research preparations
Format supplied
blend vial
Composition
Two or more compounds co-formulated in a single vial; split stated per batch
Documentation
Purity reported per component, not as a combined figure
Purity specification
Not less than 99% by reverse-phase HPLC, chromatogram enclosed
Research use only
Not a medicine. Not for human or veterinary consumption.
A blend is two or more compounds in one vial. Everything that can go wrong with a blend, and everything worth checking, comes back to whether the split is documented.
A 10 mg blend could be 5/5, 7/3 or 8/2. Without the split in writing on the certificate, every concentration you calculate afterwards is an assumption dressed as data.
A blend COA should report purity per compound, not one combined number. A single percentage across two peptides conceals which of them is the weaker material.
Two peptides sharing a vial share a pH, a counterion environment and a moisture level. Ask whether stability was assessed on the blend itself rather than on the components separately.
A blend is cheaper than two vials and involves fewer handling steps. What you give up is the ability to attribute an observation to one component, which for many study designs is the entire point.
For laboratory research purposes exclusively. Not licensed as a medicine in the UK and not intended for human or veterinary use of any kind.
Blends fail on record-keeping more often than on chemistry.
Transfer the documented split onto the vial label immediately. A concentration figure with no ratio attached is not recoverable data three months later.
Repeatedly re-entering a two-compound vial compounds both contamination risk and concentration drift across two peptides at once.
A blend is only as stable as its least stable member. Apply the stricter of the two storage regimes, not the more convenient one.
Orders placed before the daily cut-off leave the same working day, tracked and plain-packaged, with fast UK & EU delivery from Arma Nova Pharma.
Five blend preparations, each stating its total peptide load. The batch certificate documents the split between components, which is the figure to record before you reconstitute.
Product
Format
Size
Price
Stock
Yes, for laboratory research. Blended research preparations are not licensed medicines and must not be supplied or used for human or veterinary consumption.
It is the combined peptide load across all components. On its own it is not enough — you need the split between components, which should be documented on the batch certificate.
Whenever you need to attribute an observation to a specific compound. A blend permanently confounds the two variables, no matter how well documented the ratio is.
Blends suit work where the combined preparation is the object of study, and where reducing handling steps is worthwhile. If your design needs to attribute an observation to one specific compound, separate vials are the only correct choice.
Each component identified separately, with its own purity figure and molecular weight confirmation, plus the ratio in the vial. A single combined purity figure for a multi-compound blend is not adequate documentation.
Yes. A single combined percentage hides which component is the weaker material. Purity should be reported per compound on a blend certificate.
To the requirements of the least stable component. If one peptide in the vial needs darkness and −20 °C, the blend does too, regardless of what the other tolerates.
Yes, within 14 days of receipt if unopened and in original sealed packaging. Unsealed vials are excluded for health-protection reasons and your statutory rights are unaffected.
If you are comparing options, these are the guides worth reading next.